logo
  

Orion: Phase III Trial With Darolutamide Meets Primary Endpoint In MHSPC

Orion Oyj announced Orion's and Bayer's (BAYZF.PK,BAYRY.PK,BYR.L) phase III ARASENS trial showed an increase in overall survival evaluating darolutamide in combination with docetaxel and androgen deprivation therapy compared to docetaxel and androgen deprivation therapy, a standard of care in metastatic hormone-sensitive prostate cancer. The overall incidence of reported adverse events was similar between treatment arms, the company said.

Bayer plans to discuss the data from ARASENS with health authorities worldwide regarding the submission for marketing authorisation in this indication.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Retail giant Walmart is set to expand its drone delivery network to 34 sites across six states in the U.S. by the end the year through its partnership with drone delivery company DroneUp. The deliveries will reach about 4 million U.S. households in Arizona, Arkansas, Florida, Texas, Utah and Virginia. Blue Moose of Boulder LLC recalled one lot of 7 oz units of its "Spinach Artichoke Parmesan Dip" for potentially containing undeclared tree nut (Cashew) and soy allergens, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated due to mislabeling issue where a small run Spinach Artichoke Cashew Dip was labeled as Spinach Artichoke Parmesan Dip. Samsung Electronics announced that Google Assistant will be available for Galaxy Watch4 starting Tuesday. The South Korean electronics major has entered into partnership with Google to build a unified Wear OS platform for a seamless connection across Android devices. Starting Tuesday, Google Assistant will be available in 10 markets.
Follow RTT